Haagensen, E. J., Thomas, H. D., Schmalix, W. A., Payne, A. C., Kevorkian, L., Allen, R. A., . . . Newell, D. R. (2016). Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037. Cancer Chemother Pharmacol.
Chicago Style CitationHaagensen, Emma J., Huw D. Thomas, Wolfgang A. Schmalix, Andrew C. Payne, Lara Kevorkian, Rodger A. Allen, Paul Bevan, Ross J. Maxwell, i David R. Newell. "Enhanced Anti-tumour Activity of the Combination of the Novel MEK Inhibitor WX-554 and the Novel PI3K Inhibitor WX-037." Cancer Chemother Pharmacol 2016.
Cita MLAHaagensen, Emma J., et al. "Enhanced Anti-tumour Activity of the Combination of the Novel MEK Inhibitor WX-554 and the Novel PI3K Inhibitor WX-037." Cancer Chemother Pharmacol 2016.